Merck Kgaa v. Integra Lifesciences I, Ltd.

543 U.S. 1041, 125 S. Ct. 823, 160 L. Ed. 2d 609, 73 U.S.L.W. 3396, 2005 U.S. LEXIS 614

Procedural entryThis page is a short order in Merck Kgaa v. Integra Lifesciences I, Ltd.. Read the opinion of the Court — 545 U.S. 193 →

Supreme Court of the United States·Decided January 7, 2005·No. 03-1237·Published

Opinion

C. A. Fed. Cir. Motion of Eli Lilly and Company for leave to file a brief as amicus curiae granted. Certiorari granted.

Justice O’Connor and Justice Breyer took no part *1042 in the consideration or decision of this motion and this petition.

Free access — add to your briefcase to read the full text and ask questions with AI

Merck Kgaa v. Integra Lifesciences I, Ltd., 543 U.S. 1041, 125 S. Ct. 823, 160 L. Ed. 2d 609, 73 U.S.L.W. 3396, 2005 U.S. LEXIS 614 (2005).

Pincite

543 U.S. 1041 (Merck Kgaa v. Integra Lifesciences I, Ltd.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

331 F.3d 860 (Federal Circuit, 2003)